Lectra stock breaks through its 20.45 € support level and plummets 14.5%
The stock collapsed mid-morning following quarterly results that show stable activity but a decline in equipment orders. The company also warns that its 2026 growth trajectories will fall short of the roadmap. Investors have not spared the stock.
A decline that makes Lectra one of the steepest losers on the Paris exchange
Lectra stock fell 14.5% to 19.58 €, among the steepest declines on the Paris market, while the CAC 40 advanced around 1.1%. The stock has broken through its lowest level of the last 30 trading sessions at 20.45 €, a level that has become resistance. It had already declined approximately 11.6% over the week.
Only the 200-day moving average, at 19.19 €, remains below the price, with a gap of 2%. The stock thus finds itself close to this last benchmark, while the 20-day MA and 50-day MA are more than 8% above.
On the analyst side, TP Icap Midcap set a price target of 23 € today, with a hold rating, approximately 17% above the current price.
Third-quarter results: EBITDA up, but 2026 guidance revised downward
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
Third-quarter revenue remained stable on a constant currency basis, while EBITDA before non-recurring items rose 10%. Recurring revenues represent 78% of quarterly revenue. Equipment order intake, at 18.9 million euros, declined 10% on a comparable basis.
In its October 28 press release, the company mentions a market environment more degraded than anticipated: SaaS ARR growth and recurring contract revenue growth should fall short in 2026 of the average annual trajectories in the 2026-2028 roadmap (+15% and +5% to +8% on a comparable basis).
ARR reached 106.5 million euros, up 8% on a comparable basis, and non-recurring revenue declined 21%. The 19.19 € level of the 200-day MA is the next technical benchmark on the horizon.
SectorLogiciels et services numériques›Logiciels d'entreprise
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Context
Period
Period: 9M 2026
Key reported figures
Revenue: 361,3 millions d'euros
Quarterly revenue: 361,3 millions d'euros
Revenue growth: -5,7 %
EBITDA: 57,1 millions d'euros
EBITDA margin: 15,8 %
Net income: 19,6 millions d'euros
Free cash flow: 36,4 millions d'euros
62,4 millions d'euros
Guidance from the release
« Dans un environnement de marché plus dégradé qu'anticipé, l'ARR SaaS et le chiffre d'affaires des contrats récurrents poursuivent leurs croissances. Celles-ci devraient néanmoins être inférieures, sur l'exercice 2026, aux trajectoires moyennes annuelles de la feuille de route 2026-2028, soit respectivement +15 % et +5 % à +8 % à données comparables. »
Risks mentioned
Chiffre d'affaires non récurrent en diminution de 21% à données comparables
Commandes d'équipements inférieures à 2025, reflétant la moindre contribution des activités cycliques
Croissances de l'ARR SaaS et du chiffre d'affaires des contrats récurrents attendues inférieures aux trajectoires 2026-2028
Opportunities identified
ARR atteint 106,5 M€ en progression de 8% à données comparables, proche de l'objectif 2028 de plus de 100%
Ratio de sécurité à 99% de couverture des frais fixes par la marge dégagée par l'activité récurrente, proche de l'objectif 2028
Impact structurel positif de 9,1M€ sur l'EBITDA courant permettant d'absorber l'impact conjoncturel négatif
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.